Synergistic activity of troxacitabine (Troxatyl™) and gemcitabine in pancreatic cancer

BACKGROUND: Gemcitabine, a deoxycytidine nucleoside analog, is the current standard chemotherapy used as first-line treatment for patients with locally advanced or metastatic cancer of the pancreas, and extends life survival by 5.7 months. Advanced pancreatic cancer thus remains a highly unmet medic...

Descripción completa

Detalles Bibliográficos
Autores principales: Damaraju, Vijaya L, Bouffard, David Y, Wong, Clarence KW, Clarke, Marilyn L, Mackey, John R, Leblond, Lorraine, Cass, Carol E, Grey, Mike, Gourdeau, Henriette
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1948004/
https://www.ncbi.nlm.nih.gov/pubmed/17608948
http://dx.doi.org/10.1186/1471-2407-7-121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1948004/
https://www.ncbi.nlm.nih.gov/pubmed/17608948
http://dx.doi.org/10.1186/1471-2407-7-121

Ejemplares similares